2021 West Oncology | Lung Cancer | EGFR Mutation Therapy Resistance and ADCs and TROP2 Total Health | Oncology 20:34 3 years ago 2 077 Скачать Далее
Are You Prepared for the New Wave of ADCs in NSCLC? Targeting HER2, HER3, TROP2, and Others PeerView Oncology 56:23 1 year ago 5 278 Скачать Далее
2021 West Oncology | Lung Cancer | Targeted Therapies Total Health | Oncology 18:23 3 years ago 322 Скачать Далее
2021 West Oncology APP | Lung Cancer Treatments Update Total Health | Oncology 26:35 2 years ago 196 Скачать Далее
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal PeerView Oncology 51:40 1 year ago 2 042 Скачать Далее
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer ecancer 3:31 4 years ago 2 059 Скачать Далее
Current treatment recommendations and future directions for EGFR-mutant NSCLC VJOncology 1:25 2 years ago 945 Скачать Далее
Activity of EGFR TKIs in patients with NSCLC with uncommon EGFR mutations VJOncology 2:45 3 years ago 259 Скачать Далее
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC PeerView Oncology 58:24 2 years ago 1 282 Скачать Далее
2021 West Oncology | Breast Cancer | New Advances for Metastatic TNBC Total Health | Oncology 16:43 3 years ago 503 Скачать Далее
Osimertinib for EGFR T790M Resistance Mutations in NSCLC OncLive 3:59 7 years ago 1 197 Скачать Далее
GRACE Targeted Therapies Lung Cancer 2021 - Management of Uncommon EGFR Mutations Including EXON 20 GRACE - Global Resource for Advancing Cancer Education 22:49 2 years ago 80 Скачать Далее
Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum Dana-Farber Cancer Institute 20:38 1 year ago 2 353 Скачать Далее
EGFR TKIs Excite Treatment Landscape of EGFR-Mutant Lung Cancers Targeted Oncology 1:24 4 years ago 169 Скачать Далее
Targeted treatment with EGFR TKIs: Front line options HMP Education 20:24 5 years ago 3 368 Скачать Далее
